Indivior PLC Logo

Indivior PLC

Pharmaceutical company developing medicines for substance use and mental disorders.

INDV | IL

Overview

Corporate Details

ISIN(s):
GB00BN4HT335 (+2 more)
LEI:
213800V3NCQTY7IED471
Country:
United Kingdom
Address:
234 BATH ROAD, SL1 4EE SLOUGH

Description

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-24 16:52
Holding(s) in Company
English 23.4 KB
2025-07-24 09:34
Holding(s) in Company
English 25.1 KB
2025-07-23 09:08
Holding(s) in Company
English 25.1 KB
2025-07-21 17:23
Holding(s) in Company
English 25.1 KB
2025-07-21 09:33
Holding(s) in Company
English 25.1 KB
2025-07-18 09:35
Holding(s) in Company
English 25.2 KB
2025-07-17 15:00
Notice of Results
English 10.6 KB
2025-07-01 09:43
Holding(s) in Company
English 56.2 KB
2025-07-01 08:49
Total Voting Rights
English 4.8 KB
2025-06-30 08:00
Indivior Announces Inclusion in US Russell Indexes
English 12.9 KB
2025-06-25 08:00
Indivior Appoints Tony Kingsley to the Board
English 14.0 KB
2025-06-17 17:42
Holding(s) in Company
English 26.7 KB
2025-06-13 09:10
Director/PDMR Shareholding - Correction
English 28.2 KB
2025-06-12 17:24
Director/PDMR Shareholding
English 26.9 KB
2025-06-10 17:12
Holding(s) in Company
English 26.8 KB

Automate Your Workflow. Get a real-time feed of all Indivior PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Indivior PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Indivior PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bone Biologics Corp Logo
Develops a protein-based bone graft substitute for spinal fusion procedures.
United States of America
BBLG
Bonyf N.V. Logo
Develops medical devices for oral, dental, orthodontic, and dermatological care.
Belgium
MLBON
Boryung Corporation Logo
A healthcare company developing pharmaceuticals and investing in health sector innovation.
South Korea
003850
Bosnalijek d.d. Sarajevo Logo
Develops, manufactures, and exports a wide range of pharmaceutical products.
Bosnia and Herzegovina
BSNL
Boule Diagnostics Logo
Provider of hematology systems for decentralized human and veterinary markets.
Sweden
BOUL
Boundless Bio, Inc. Logo
Clinical-stage oncology company targeting ecDNA in oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma developing inhibitors for genetically driven cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Develops selective serotonin agonists for neurological and psychiatric disorders.
United States of America
DRUG
A clinical-stage biopharma company developing cancer immunotherapies and cell therapies.
Japan
4594

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.